कृपया अन्य खोज का प्रयास करें
Coegin Pharma AB, a biotechnology company, engages in the discovery and development of dermacosmetic products and drugs for the treatment of serious diseases associated with diabetes and cancer. Its products include AVX001 GEL drug candidate, which is in phase 2 clinical study for the treatment of actinic keratosis and in phase 1 clinical study for the treatment of basal cell carcinoma; AVX420 drug candidate in preclinical study for the indication of leukemia; FOL026, a peptide-based drug in preclinical study for the prevention of cardiovascular complications in diabetes; AVX420/FOL026 therapy in preclinical study for the treatment of kidney and liver fibrosis; and FOL005 for the treatment of stimulation of hair growth. The company was founded in 2005 and is based in Lund, Sweden.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Odd Hjelmeland | - | - | Director |
Jan Erik Foss | - | - | Director |
Mikael Ørum | - | - | Chief Executive Officer and President |
Farzad Abdi-Dezfuli | - | - | Director |
J. A. Jongejan | - | - | Member of Scientific Advisory Board |
Edward A. Dennis | 81 | - | Member of Scientific Advisory Board |
Erlend Skagseth | 68 | 2020 | Director |
Joseph V. Bonventre | 73 | - | Member of Scientific Advisory Board |
Jorgen Serup | - | - | Member of Scientific Advisory Board |
George Kokotos | - | - | Member of Scientific Advisory Board |
Thoas Fioretos | 61 | 2022 | Director |
Eva Sjokvist Saers | 61 | 2023 | Chairman of the Board |
Jens Eriksson | 49 | 2023 | CEO & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है